Abstract
We present a case of fungal peritonitis in a patient secondary to intestinal perforation and repeated laparotomy. An analysis of data from the register of patients with invasive candidiasis is also presented. In the study were included 42 patients with candida peritonitis. The risk factors: antibiotics (100%), vascular catheters (95%), total parenteral nutrition (81%), repeated abdominal surgery (69%), sepsis (69%), bacteremia (50%), repeated perforations on the gastrointestinal tract (43%), oncopathology of the gastrointestinal tract (36%), infected pancreatic necrosis (26%). The etiology agents were C. albicans (50%), C. glabrata (14%), C. parapsilosis (7%). 45% of patients received prophylactic treatment (100% fluconazole). Empirical therapy was carried out by 52% of patients (triazoles – 38%, echinocandins – 14%). After receiving the results of the microbiological study, 3% of patients began to receive antifungal therapy (echinocandins). The 30 days overall survival rate was 66%.
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Leningrad Regional Clinical Hospital, St. Petersburg, Russia
Leningrad Regional Clinical Hospital, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
St. Petersburg Research Institute of Emergency Care named after I.I. Dzhanelidze, St. Petersburg, Russia
St. Petersburg Research Institute of Emergency Care named after I.I. Dzhanelidze, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Kashkin Research Institute of Medical Mycology at the North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
-
1.
McCarty T.P., Pappas P.G. Invasive candidiasis. Infect Dis Clin North Am. 2016;30:103-124.
DOI: 10.1016/j.idc.2015.10.013
-
2.
Bongomin F., Gago S., Oladele R.O., Denning D.W. Global and multi-national prevalence of fungal diseasesestimate precision. J Fungi (Basel). 2017;3:57.
DOI: 10.3390/jof3040057
-
3.
Wisplinghoff H., Ebbers J., Geurtz L., Stefanik D., Major Y., Edmond M.B., et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43:78-81.
DOI: 10.1016/j.ijantimicag.2013.09.005
-
4.
Koehler P., Stecher M., Cornely O.A., Koehler D., Vehreschild M.J.G.T., Bohliuset J., et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic metaanalysis. Clin Microbiol Infect. 2019;25:1200-1212.
DOI: 10.1016/j.cmi.2019.04.024
-
5.
Bassetti M., Giacobbe D.R., Vena A., Trucchi C., Ansaldi F., Antonelli M., et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23:219.
DOI: 10.1186/s13054-019-2497-3
-
6.
Klimko N.N., Rubinchik V.E., Sobol M.M., Larionova V.B., Tyrenko V.V., Talipova L.I., et al. Results of a prospective multicenter study of anidulafungin – ERA. Problemy meditsinskoi mikologii. 2018;20(3):21-25. Russian.
-
7.
Barantsevich N., Barantsevich E. Diagnosis and treatment of invasive candidiasis. Antibiotics (Basel). 2022;11(6):718.
DOI: 10.3390/antibiotics11060718
-
8.
Clancy C.J., Nguyen M.H. Diagnosing invasive candidiasis. J Clin Microbiol. 2018;56(5):e01909-17.
DOI: 10.1128/JCM.01909-17
-
9.
Pramod J., Vijayakumar C., Srinivasan K., Maroju N.K., Raj Kumar N., Balasubramaniyan G. Clinical significance of Candida in an intraoperative peritoneal specimen with perforation peritonitis: an institutional perspective. Cureus. 2018;10(3):e2275.
DOI: 10.7759/cureus.2275
-
10.
Shankar M., Uwamahoro N., Backman E., Holmberg S., Niemiec M.J., Roth J., et al. Immune resolution dilemma: host antimicrobial factor S100A8/A9 modulates inflammatory collateral tissue damage during disseminated fungal peritonitis. Front Immunol. 2022;12:553911.
DOI: 10.3389/fimmu.2021.553911
-
11.
Fiore M., Leone S. Spontaneous fungal peritonitis: epidemiology, current evidence and future prospective. World J Gastroenterol. 2016;22(34):7742-7747.
DOI: 10.3748/wjg.v22.i34.7742
-
12.
Paoli C.J., Reynolds M.A., Sinha M., Gitlin M., Crouser E. epidemiology and costs of sepsis in the United States – an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889-1897.
DOI: 10.1097/CCM.0000000000003342
-
13.
Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009;29(Suppl. 2):161165. PMID: 19270208.
-
14.
Cheng S., Clancy C.J., Hartman D.J., Hao B., Nguyen M.H. Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses. Infect Immun. 2014;82(7):3015-3022.
DOI: 10.1128/IAI.00062-14
-
15.
Juarez V. D., Cano E. K., Toledo R. S., et al. Fungal peritonitis associated with peritoneal dialysis due to non-albicans Candida: a case series. Cureus. 2022;14(12):e32658.
DOI: 10.7759/cureus.32658
-
16.
Klimko N.N. Mycoses: diagnosis and treatment. – M.: Vi Dzhi Grupp 2017. 336 p. Russian.
-
17.
Schulze J., Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int. 2009;106(5152):837-842.
DOI: 10.3238/arztebl.2009.0837
-
18.
Johnson D.W., Cobb J.P. Candida infection and colonization in critically ill surgical patients. Virulence. 2010;1(5):355-356.
DOI: 10.4161/viru.1.5.13254
-
19.
Carneiro H.A., Mavrakis A., Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011;35(12):2650-2609.
DOI: 10.1007/s00268-011-1305-2
-
20.
Sandven P., Qvist H., Skovlund E., Giercksky K.E.; NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002;30:541-547.
DOI: 10.1097/00003246-200203000-00008
-
21.
Bassetti M., Vena A., Giacobbe D.R., Trucchi C., Ansaldi F., Antonelli M., et. al.; from the Study Group for Infections in Critically Ill Patients (ESGCIP) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Risk factors for intra-abdominal candidiasis in intensive care units: results from EUCANDICU study. Infect Dis Ther. 2022;11(2):827-840.
DOI: 10.1007/s40121021-00585-6
-
22.
Munoz P., Agnelli C., Guinea J., Vena A., ÁlvarezUría A., Marcos-Zambrano L.J., et al. Is biofilm production a prognostic marker in adults with candidaemia? Clin Microbiol Infect. 2018;24(9):1010-1015.
DOI: 10.1016/j.cmi.2018.01.022
-
23.
Leiderman I.N., Yaroshetskii A.I., Kokarev E.A., Mazurok V.A. Parenteral nutrition: questions and answers. Guidelines for doctors. – SPb.: Onli-Press 2016.192 p. Russian.
-
24.
Singer M., Deutschman C.S., Seymour C.W., ShankarHari M., Annane D., Bauer M., et. al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801-810.
DOI: 10.1001/jama.2016.0287
-
25.
Hwang S.Y., Yu S.J., Lee J.H., Kim J.S., Yoon J.W., Kim Y.J., et al. Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis. 2014;33(2):259-264.
DOI: 10.1007/s10096-013-1953-2
-
26.
Varda B., Alani M., Ahmed S. A rare case of spontaneous fungal peritonitis caused by Candida lusitaniae in a patient with necrotizing pancreatitis. Cureus. 2023;15(6):e40237.
DOI: 10.7759/cureus.40237
-
27.
Jensen J.U., Hein L., Lundgren B., Bestle M.H., Mohr T., Andersen M.H., et al. Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime. Crit Care Med. 2015;43(3):594-602.
DOI: 10.1097/CCM.0000000000000746
-
28.
Zaoutis T.E., Prasad P.A., Localio A.R., Coffin S.E., Bell L.M., Walsh T.J., et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51(5):38-45.
DOI: 10.1086/655698
-
29.
Dudoignon E., Alanio A., Anstey J., Depret F., Coutrot M., Fratani A., et al. Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: a matched cohort study. Mycoses. 2019;62(3):237-246.
DOI: 10.1111/myc.12872
-
30.
Seagle E., Brendan R J., Lockhart S.R., Georgacopoulos O., Nunnally N.S., Roland J., et. al. The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2022;74(5):802-811.
DOI: 10.1093/cid/ciab562
-
31.
Li W.S., Lee C.H., Liu J.W. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid. J Microbiol Immunol Infect. 2017;50(3):370-376.
DOI: 10.1016/j.jmii.2015.07.004
-
32.
Claessen J.J.M., van den Berg F.F., Boermeester M.A. The challenge of postoperative peritonitis due to anastomotic leakage. In: Infections in surgery: prevention and management; 2021. 143 p.
DOI: 10.1007/978-3-03062116-2_13
-
33.
Nguyen T.K., Nguyen H.H., Nguyen C.L., Luong T.H., Dinh L.D., Le V.D., et al. Case report: candidiasis of gastrojejunostomosis after pancreaticoduodenectomy: preliminary experience from two cases. Front Oncol. 2022;12:888927.
DOI: 10.3389/fonc.2022.888927
-
34.
Lagunes L., Borgatta B., Martín-Gomez M.T., Rey-Pérez A., Antonelli M., Righi E., et. al. Predictors of choice of initial antifungal treatment in intraabdominal candidiasis. Clin Microbiol Infect. 2016;22(8):719-724.
DOI: 10.1016/j.cmi.2016.06.005
-
35.
Klimko N.N. Diagnosis and treatment of mycoses in intensive care units. Russian recommendations. 2nd edition expanded and revised. M.: Farmtek 2015. 96 p. Russian.
-
36.
Worasilchai N., Leelahavanichkul A., Kanjanabuch T., Thongbor N., Lorvinitnun P., Sukhontasing K., et. al. (1→3)-β-d-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study. Med Mycol. 2015;53:338-436.
DOI: 10.1093/mmy/myv007
-
37.
Hou T.Y., Wang S.H., Liang S.X., Jiang W.X., Luo D.D., Huang D.H. The screening performance of serum 1,3-betad-glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies. PLoS One. 2015;10:e0131602.
DOI: 10.1371/journal.pone.0131602
-
38.
Cornely O.A., Bassetti M., Calandra T., Garbino J., Kullberg B.J., Lortholary O., et. al., ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl. 7):19-37.
DOI: 10.1111/1469-0691.12039
-
39.
Pappas P.G., Kauffman C.A., Andes D.R., Clancy C.J., Marr K.A., Ostrosky-Zeichner L., et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50.
DOI: 10.1093/cid/civ933
-
40.
Mellinghoff S.C., Hoenigl M., Koehler P., Kumar A., Lagrou K., Lass-Florl C., et al. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses. 2018;61(5):326-330.
DOI: 10.1111/myc.12746
-
41.
Pittet D., Monod M., Suter P., Frenk E., Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751-758.
DOI: 10.1097/00000658-199412000-00008
-
42.
Hall A., Poole L., Renton B., Wozniak A., Fisher M., Neal T., et al. Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis. Crit Care. 2013;17:49.
DOI: 10.1186/cc12569
-
43.
Bassetti M., Marchetti M., Chakrabarti A., Colizza S., Garnacho-Montero J., Kett D.H., et al. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39(12):2092-2106.
DOI: 10.1007/s00134013-3109-3
-
44.
Van Santvoort H.C., Bakker O.J., Bollen T.L., Besselink M.G., Ahmed Ali U., Schrijver A.M., et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology. 2011;141(4):12541263.
DOI: 10.1053/j.gastro.2011.06.073
-
45.
Montravers P., Dupont H., Gauzit R., Veber B., Auboyer C., Blin P., Hennequin C., Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34(3):646652.
DOI: 10.1097/01.CCM.0000201889.39443.D2
-
46.
Arveen S., Jagdish S., Kadambari D. Perforated peptic ulcer in South India: an institutional perspective. World J Surg. 2009;33:1600-1604.
DOI: 10.1007/s00268009-0056-9
-
47.
Yan T., Li S.L., Ou H.L., Zhu S.N., Huang L., Wang D.X. Appropriate source control and antifungal therapy are associated with improved survival in critically ill surgical patients with intra-abdominal candidiasis. World J Surg. 2020;44(5):1459-1469.
DOI: 10.1007/s00268-02005380-x